 | • レポートコード：MRC2312MG11991 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、78ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のウイルス凍結保存市場規模と予測を収録しています。・世界のウイルス凍結保存市場：売上、2018年-2023年、2024年-2029年 ・世界のウイルス凍結保存市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のウイルス凍結保存市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「植物ウイルス凍結液」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ウイルス凍結保存のグローバル主要企業は、ATCC、 Kerafast、 Virovek、 Virusys Corporation、 Microbix Biosystems、 Eureka Therapeutic、 Vigene Biosciences、 Oxford Biomedica、 Cobra Biologics、 Lonza、 BioRelianceなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ウイルス凍結保存のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のウイルス凍結保存市場：タイプ別、2018年-2023年、2024年-2029年 世界のウイルス凍結保存市場：タイプ別市場シェア、2022年 ・植物ウイルス凍結液、動物ウイルス凍結液 世界のウイルス凍結保存市場：用途別、2018年-2023年、2024年-2029年 世界のウイルス凍結保存市場：用途別市場シェア、2022年 ・医療、科学研究 世界のウイルス凍結保存市場：地域・国別、2018年-2023年、2024年-2029年 世界のウイルス凍結保存市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるウイルス凍結保存のグローバル売上、2018年-2023年 ・主要企業におけるウイルス凍結保存のグローバル売上シェア、2022年 ・主要企業におけるウイルス凍結保存のグローバル販売量、2018年-2023年 ・主要企業におけるウイルス凍結保存のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 ATCC、 Kerafast、 Virovek、 Virusys Corporation、 Microbix Biosystems、 Eureka Therapeutic、 Vigene Biosciences、 Oxford Biomedica、 Cobra Biologics、 Lonza、 BioReliance ************************************************************* ・調査・分析レポートの概要 ウイルス凍結保存市場の定義 市場セグメント 世界のウイルス凍結保存市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のウイルス凍結保存市場規模 世界のウイルス凍結保存市場規模：2022年 VS 2029年 世界のウイルス凍結保存市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのウイルス凍結保存の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のウイルス凍結保存製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：植物ウイルス凍結液、動物ウイルス凍結液 ウイルス凍結保存のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：医療、科学研究 ウイルス凍結保存の用途別グローバル売上・予測 ・地域別市場分析 地域別ウイルス凍結保存市場規模 2022年と2029年 地域別ウイルス凍結保存売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） ATCC、 Kerafast、 Virovek、 Virusys Corporation、 Microbix Biosystems、 Eureka Therapeutic、 Vigene Biosciences、 Oxford Biomedica、 Cobra Biologics、 Lonza、 BioReliance ... |
This research report provides a comprehensive analysis of the Virus Cryopreservation market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Virus Cryopreservation market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Virus Cryopreservation, challenges faced by the industry, and potential opportunities for market players.
The global Virus Cryopreservation market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Virus Cryopreservation market presents opportunities for various stakeholders, including Medical, Scientific Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Virus Cryopreservation market. Additionally, the growing consumer demand present avenues for market expansion.
The global Virus Cryopreservation market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Virus Cryopreservation market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Virus Cryopreservation market.
Market Overview: The report provides a comprehensive overview of the Virus Cryopreservation market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Plant Virus Freezing Solution, Animal Virus Freezing Solution), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Virus Cryopreservation market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Virus Cryopreservation market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Virus Cryopreservation market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Virus Cryopreservation market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Virus Cryopreservation market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Virus Cryopreservation market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Virus Cryopreservation, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Virus Cryopreservation market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Virus Cryopreservation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Plant Virus Freezing Solution
Animal Virus Freezing Solution
Market segment by Application
Medical
Scientific Research
Global Virus Cryopreservation Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
ATCC
Kerafast
Virovek
Virusys Corporation
Microbix Biosystems
Eureka Therapeutic
Vigene Biosciences
Oxford Biomedica
Cobra Biologics
Lonza
BioReliance
Outline of Major Chapters:
Chapter 1: Introduces the definition of Virus Cryopreservation, market overview.
Chapter 2: Global Virus Cryopreservation market size in revenue and volume.
Chapter 3: Detailed analysis of Virus Cryopreservation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Virus Cryopreservation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Virus Cryopreservation capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Virus Cryopreservation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Virus Cryopreservation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Virus Cryopreservation Overall Market Size
2.1 Global Virus Cryopreservation Market Size: 2022 VS 2029
2.2 Global Virus Cryopreservation Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Virus Cryopreservation Sales: 2018-2029
3 Company Landscape
3.1 Top Virus Cryopreservation Players in Global Market
3.2 Top Global Virus Cryopreservation Companies Ranked by Revenue
3.3 Global Virus Cryopreservation Revenue by Companies
3.4 Global Virus Cryopreservation Sales by Companies
3.5 Global Virus Cryopreservation Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Virus Cryopreservation Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Virus Cryopreservation Product Type
3.8 Tier 1, Tier 2 and Tier 3 Virus Cryopreservation Players in Global Market
3.8.1 List of Global Tier 1 Virus Cryopreservation Companies
3.8.2 List of Global Tier 2 and Tier 3 Virus Cryopreservation Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Virus Cryopreservation Market Size Markets, 2022 & 2029
4.1.2 Plant Virus Freezing Solution
4.1.3 Animal Virus Freezing Solution
4.2 By Type – Global Virus Cryopreservation Revenue & Forecasts
4.2.1 By Type – Global Virus Cryopreservation Revenue, 2018-2023
4.2.2 By Type – Global Virus Cryopreservation Revenue, 2024-2029
4.2.3 By Type – Global Virus Cryopreservation Revenue Market Share, 2018-2029
4.3 By Type – Global Virus Cryopreservation Sales & Forecasts
4.3.1 By Type – Global Virus Cryopreservation Sales, 2018-2023
4.3.2 By Type – Global Virus Cryopreservation Sales, 2024-2029
4.3.3 By Type – Global Virus Cryopreservation Sales Market Share, 2018-2029
4.4 By Type – Global Virus Cryopreservation Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Virus Cryopreservation Market Size, 2022 & 2029
5.1.2 Medical
5.1.3 Scientific Research
5.2 By Application – Global Virus Cryopreservation Revenue & Forecasts
5.2.1 By Application – Global Virus Cryopreservation Revenue, 2018-2023
5.2.2 By Application – Global Virus Cryopreservation Revenue, 2024-2029
5.2.3 By Application – Global Virus Cryopreservation Revenue Market Share, 2018-2029
5.3 By Application – Global Virus Cryopreservation Sales & Forecasts
5.3.1 By Application – Global Virus Cryopreservation Sales, 2018-2023
5.3.2 By Application – Global Virus Cryopreservation Sales, 2024-2029
5.3.3 By Application – Global Virus Cryopreservation Sales Market Share, 2018-2029
5.4 By Application – Global Virus Cryopreservation Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Virus Cryopreservation Market Size, 2022 & 2029
6.2 By Region – Global Virus Cryopreservation Revenue & Forecasts
6.2.1 By Region – Global Virus Cryopreservation Revenue, 2018-2023
6.2.2 By Region – Global Virus Cryopreservation Revenue, 2024-2029
6.2.3 By Region – Global Virus Cryopreservation Revenue Market Share, 2018-2029
6.3 By Region – Global Virus Cryopreservation Sales & Forecasts
6.3.1 By Region – Global Virus Cryopreservation Sales, 2018-2023
6.3.2 By Region – Global Virus Cryopreservation Sales, 2024-2029
6.3.3 By Region – Global Virus Cryopreservation Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Virus Cryopreservation Revenue, 2018-2029
6.4.2 By Country – North America Virus Cryopreservation Sales, 2018-2029
6.4.3 US Virus Cryopreservation Market Size, 2018-2029
6.4.4 Canada Virus Cryopreservation Market Size, 2018-2029
6.4.5 Mexico Virus Cryopreservation Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Virus Cryopreservation Revenue, 2018-2029
6.5.2 By Country – Europe Virus Cryopreservation Sales, 2018-2029
6.5.3 Germany Virus Cryopreservation Market Size, 2018-2029
6.5.4 France Virus Cryopreservation Market Size, 2018-2029
6.5.5 U.K. Virus Cryopreservation Market Size, 2018-2029
6.5.6 Italy Virus Cryopreservation Market Size, 2018-2029
6.5.7 Russia Virus Cryopreservation Market Size, 2018-2029
6.5.8 Nordic Countries Virus Cryopreservation Market Size, 2018-2029
6.5.9 Benelux Virus Cryopreservation Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Virus Cryopreservation Revenue, 2018-2029
6.6.2 By Region – Asia Virus Cryopreservation Sales, 2018-2029
6.6.3 China Virus Cryopreservation Market Size, 2018-2029
6.6.4 Japan Virus Cryopreservation Market Size, 2018-2029
6.6.5 South Korea Virus Cryopreservation Market Size, 2018-2029
6.6.6 Southeast Asia Virus Cryopreservation Market Size, 2018-2029
6.6.7 India Virus Cryopreservation Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Virus Cryopreservation Revenue, 2018-2029
6.7.2 By Country – South America Virus Cryopreservation Sales, 2018-2029
6.7.3 Brazil Virus Cryopreservation Market Size, 2018-2029
6.7.4 Argentina Virus Cryopreservation Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Virus Cryopreservation Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Virus Cryopreservation Sales, 2018-2029
6.8.3 Turkey Virus Cryopreservation Market Size, 2018-2029
6.8.4 Israel Virus Cryopreservation Market Size, 2018-2029
6.8.5 Saudi Arabia Virus Cryopreservation Market Size, 2018-2029
6.8.6 UAE Virus Cryopreservation Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ATCC
7.1.1 ATCC Company Summary
7.1.2 ATCC Business Overview
7.1.3 ATCC Virus Cryopreservation Major Product Offerings
7.1.4 ATCC Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.1.5 ATCC Key News & Latest Developments
7.2 Kerafast
7.2.1 Kerafast Company Summary
7.2.2 Kerafast Business Overview
7.2.3 Kerafast Virus Cryopreservation Major Product Offerings
7.2.4 Kerafast Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.2.5 Kerafast Key News & Latest Developments
7.3 Virovek
7.3.1 Virovek Company Summary
7.3.2 Virovek Business Overview
7.3.3 Virovek Virus Cryopreservation Major Product Offerings
7.3.4 Virovek Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.3.5 Virovek Key News & Latest Developments
7.4 Virusys Corporation
7.4.1 Virusys Corporation Company Summary
7.4.2 Virusys Corporation Business Overview
7.4.3 Virusys Corporation Virus Cryopreservation Major Product Offerings
7.4.4 Virusys Corporation Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.4.5 Virusys Corporation Key News & Latest Developments
7.5 Microbix Biosystems
7.5.1 Microbix Biosystems Company Summary
7.5.2 Microbix Biosystems Business Overview
7.5.3 Microbix Biosystems Virus Cryopreservation Major Product Offerings
7.5.4 Microbix Biosystems Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.5.5 Microbix Biosystems Key News & Latest Developments
7.6 Eureka Therapeutic
7.6.1 Eureka Therapeutic Company Summary
7.6.2 Eureka Therapeutic Business Overview
7.6.3 Eureka Therapeutic Virus Cryopreservation Major Product Offerings
7.6.4 Eureka Therapeutic Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.6.5 Eureka Therapeutic Key News & Latest Developments
7.7 Vigene Biosciences
7.7.1 Vigene Biosciences Company Summary
7.7.2 Vigene Biosciences Business Overview
7.7.3 Vigene Biosciences Virus Cryopreservation Major Product Offerings
7.7.4 Vigene Biosciences Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.7.5 Vigene Biosciences Key News & Latest Developments
7.8 Oxford Biomedica
7.8.1 Oxford Biomedica Company Summary
7.8.2 Oxford Biomedica Business Overview
7.8.3 Oxford Biomedica Virus Cryopreservation Major Product Offerings
7.8.4 Oxford Biomedica Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.8.5 Oxford Biomedica Key News & Latest Developments
7.9 Cobra Biologics
7.9.1 Cobra Biologics Company Summary
7.9.2 Cobra Biologics Business Overview
7.9.3 Cobra Biologics Virus Cryopreservation Major Product Offerings
7.9.4 Cobra Biologics Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.9.5 Cobra Biologics Key News & Latest Developments
7.10 Lonza
7.10.1 Lonza Company Summary
7.10.2 Lonza Business Overview
7.10.3 Lonza Virus Cryopreservation Major Product Offerings
7.10.4 Lonza Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.10.5 Lonza Key News & Latest Developments
7.11 BioReliance
7.11.1 BioReliance Company Summary
7.11.2 BioReliance Business Overview
7.11.3 BioReliance Virus Cryopreservation Major Product Offerings
7.11.4 BioReliance Virus Cryopreservation Sales and Revenue in Global (2018-2023)
7.11.5 BioReliance Key News & Latest Developments
8 Global Virus Cryopreservation Production Capacity, Analysis
8.1 Global Virus Cryopreservation Production Capacity, 2018-2029
8.2 Virus Cryopreservation Production Capacity of Key Manufacturers in Global Market
8.3 Global Virus Cryopreservation Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Virus Cryopreservation Supply Chain Analysis
10.1 Virus Cryopreservation Industry Value Chain
10.2 Virus Cryopreservation Upstream Market
10.3 Virus Cryopreservation Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Virus Cryopreservation Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
